Edward Kavalerchik

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Chronic myeloid leukemia stem cells
    Edward Kavalerchik
    Division of Hematology Oncology, Department of Internal Medicine, Moores Cancer Center, 3855 Health Science Rd, University of California San Diego, CA 92093 0820, USA
    J Clin Oncol 26:2911-5. 2008
  2. doi request reprint Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors
    Ifat Geron
    Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA
    Cancer Cell 13:321-30. 2008

Collaborators

Detail Information

Publications2

  1. doi request reprint Chronic myeloid leukemia stem cells
    Edward Kavalerchik
    Division of Hematology Oncology, Department of Internal Medicine, Moores Cancer Center, 3855 Health Science Rd, University of California San Diego, CA 92093 0820, USA
    J Clin Oncol 26:2911-5. 2008
    ..Combined therapies targeting aberrant properties of LSC may obviate therapeutic resistance and relapse in advanced phase and therapeutically recalcitrant CML...
  2. doi request reprint Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors
    Ifat Geron
    Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA
    Cancer Cell 13:321-30. 2008
    ..Thus, TG101348 may be an effective inhibitor of JAK2V617F+ MPDs in clinical trials...